Clinical Trial Update: Community-associated Highly-Resistant Enterobacterales

View source ↗

Summary

A UNC-Chapel Hill sponsor completed a clinical trial investigating community-associated highly-resistant Enterobacterales infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Enterobacteriaceae Infection
• Community-acquired Infection
• Enterobacteriaceae Infection
• Healthcare-associated Infection

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Enterobacteriaceae Infections, Community-Acquired Infections | Status: COMPLETED